EU Trade Commissioner Phil Hogan issues statement on European Union compulsory licensing in context of COVID-19, makes important statement about TRIPS Article 31bis

On 14 May 2020, Bernd Lange, Chair of the European Parliament’s Committee on International Trade (INTA) wrote a letter to Phil Hogan (Commissioner for Trade, European Commission) on the “commercial aspects of intellectual property rights for medical products in the… Continue Reading

14 May 2020 – The WHO Covid-19 Technology Pool: The solution to ensure global access to Covid-19 health technologies

Livestream here: https://www.youtube.com/watch?v=iNMpuQfH088 On 14 May 2020, Health Action International, Knowledge Ecology International, Medicines Law & Policy, Pharmaceutical Accountability Foundation, and Wemos will convene a briefing entitled: “The WHO Covid-19 Technology Pool: The solution to ensure global access to Covid-19… Continue Reading

KEI comments on the resolution WHA73: “Covid-19 Response” proposed by the European Union

On Friday, 24 April 2020, Knowledge Ecology International submitted comments on the resolution WHA73: “Covid-19 Response” proposed by the European Union (EU). The original zero draft text and the note verbale proposed by the European Union can be found here.… Continue Reading

Israel issues compulsory license to allow the government to import generic versions of Kaletra

(More on COVID-19 here: https://www.keionline.org/coronavirus) On Wednesday, 18 March 2020 (22nd of Adar, 5780), Israel’s Minister of Health, MP Rabbi Yaacov Litzman, issued a Permit to the State to Exploit an Invention Pursuant to Chapter Six, Article Three of the… Continue Reading